Clinical trials for neuroblastoma
For children with neuroblastoma, clinical trials may offer access to treatments that are not yet part of standard care. This page helps you understand what clinical trials are, how they work, and provides information to support you in considering whether a clinical trial may be right for your child.
Understanding clinical trials
Other useful information about clinical trials
-
-
How can I fundraise for neuroblastoma treatment outside of the NHS?
-
How can I get support to access treatment not available on the NHS?
-
Should I be fundraising for additional treatment for neuroblastoma?
-
What support is there to help me make treatment decisions?
-
Should I enroll my child on a clinical trial for neuroblastoma?
-
Can I change my mind about enrolling my child on a clinical trial?
-
Useful videos
Watch videos exploring neuroblastoma clinical trials, new treatment approaches, and the latest research developments.
-
Video (2025)Treating relapsed and refractory disease
An overview of clinical trials and new treatments for relapsed and refractory neuroblastoma.
-
Video (2025)Car T-cell therapy
An introduction to CAR T‑cell therapy for relapsed and refractory neuroblastoma, including how it works and emerging research.
-
Video (2026)Bambino Gesù CAR T-cell trial
Explore the Bambino Gesù CAR T-cell trial in Rome and its expansion across Europe.
-
VideoRelapse strategies and trials
Explores COG/NANT treatment strategies and clinical trials for relapsed neuroblastoma, including targeted and immunotherapies.
-
Video (2026)BEACON2
Learn about the BEACON2 trial for relapsed neuroblastoma, including its aims and potential side effects.
-
Video (2026)The MINT study
A simple overview of the MINT study and new approaches being explored for treating high‑risk neuroblastoma.
-
VideoCAR T-cell therapies: where are we now?
Explores CAR T‑cell therapy as an emerging treatment, particularly in relapsed disease.
-
Video (2026)Finding trusted information
Hear from parents and healthcare professionals about finding trusted neuroblastoma information and avoiding misinformation.
-
VideoAdvances in immunotherapy
Explore developments in ongoing clinical trials and emerging combination therapies for relapsed and refractory neuroblastoma.
-
VideoAnti-GD2 antibody therapy
Overview the role of anti-GD2 antibody therapy in the treatment of neuroblastoma, including BEACON Immuno and MiNivAN clinical trials.